These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11374366)

  • 1. Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.
    Klumpp TR
    N Engl J Med; 2001 May; 344(21):1641; author reply 1641-2. PubMed ID: 11374366
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.
    Goker H
    N Engl J Med; 2001 May; 344(21):1641; author reply 1641-2. PubMed ID: 11374367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Choice of stem cell source in hematopoietic cell transplantation].
    Yabe H
    Rinsho Ketsueki; 2005 Jun; 46(6):399-409. PubMed ID: 16447721
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood.
    Singhal S; Powles R; Mehta J
    N Engl J Med; 2001 May; 344(21):1641; author reply 1641-2. PubMed ID: 11374365
    [No Abstract]   [Full Text] [Related]  

  • 6. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update.
    Vigorito AC; Marques Júnior JF; Aranha FJ; Oliveira GB; Miranda EC; De Souza CA
    Haematologica; 2001 Jun; 86(6):665-6. PubMed ID: 11418381
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients.
    Lange A; Karabon L; Klimczak A; Dłubek D; Bogunia-Kubik K; Swider C; Suchnicki K
    Transplant Proc; 1996 Dec; 28(6):3522-5. PubMed ID: 8962369
    [No Abstract]   [Full Text] [Related]  

  • 11. Is there an upper age limit for bone marrow transplantation?
    Popplewell LL; Forman SJ
    Bone Marrow Transplant; 2002 Feb; 29(4):277-84. PubMed ID: 11896423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
    Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow transplantation].
    Sosa-Sánchez R; Deeg HJ; Sobrevilla-Calvo P
    Rev Invest Clin; 1997 May; 49 Suppl 1():75-82. PubMed ID: 9380993
    [No Abstract]   [Full Text] [Related]  

  • 16. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
    Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
    J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives.
    Ringdén O; Le Blanc K
    APMIS; 2005; 113(11-12):813-30. PubMed ID: 16480452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell therapy for malignant diseases.
    Shapira MY; Hai AA; Tsirigotis P; Resnick IB; Or R; Slavin S
    Ann Med; 2007; 39(6):465-73. PubMed ID: 17852026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.